newsonline24

As part of this transformation, EvidentIQ Germany GmbH is now operating under the name AB Cube Germany GmbH. In addition, asthenis Medical GmbH has been integrated into AB Cube Germany GmbH. 

This combination strengthens AB Cube’s footprint in Germany and Europe and expands its offering for life-science organizations — covering clinical data management, structured oncology documentation, tumor boards, and regulatory safety processes. 

Integrated solutions for oncology research and safety 

The transformation unites three complementary strengths: 

• Marvin — clinical data management for clinical trials and registries, with a strong focus on oncology workflows 
• asthenis — tumor documentation, oncology registries, and multidisciplinary tumor boards 
• SafetyEasy® — pharmacovigilance, vigilance, and regulatory safety workflows 

The integration links Marvin’s oncology trial expertise with asthenis’ strengths in tumor documentation and tumor boards, that connects clinical trial data with structured real-world oncology care data. 

SafetyEasy® complements the portfolio by adding safety and vigilance workflows, enabling a more integrated approach across clinical trials, real-world data, and regulatory compliance. 

Together, AB Cube Group now supports customers with an integrated set of tools for: 

• Clinical data management for studies and registries 
• Oncology documentation and structured real-world data capture 
• Tumor conferences and tumor boards 
• Pharmacovigilance and vigilance reporting 
• Regulatory compliance workflows 

For further information on AB Cube Group, please contact AB Cube Germany GmbH. 

About AB Cube SAS AB Cube SAS is a pioneer in cloud-based vigilance and safety software for the life sciences industry. Since 2006, AB Cube has developed innovative SaaS solutions, including the SafetyEasy® Suite, that help organizations worldwide manage complex safety, pharmacovigilance, medical device vigilance, cosmetic vigilance, and regulatory reporting workflows with flexibility, automation, and compliance at their core.